KCAS Bioanalytical and Biomarker Services Establish Olathe, Kansas, Lab
The new bioanalytical facility, one of the largest in the country, will provide advanced technology and expertise across the complete R&D range of discovery, preclinical, and clinical studies.
“We are proud to officially celebrate the grand opening of our new purpose-built facility positioned in the Kansas Bioscience Park campus.?The support of state and local leadership has been instrumental in KCAS making Kansas home to our growing organization,” said KCAS CEO John Bucksath.?“This investment, along with the recent acquisitions of FlowMetric and Active Biomarkers, has positioned KCAS for global expansion and significant gains in capacity that allow us to attract expertise and serve our customers as the CRO of choice for the global pharma and biopharma industries. As one of the area’s largest employers, we continue to look for top talent to help us grow both locally and globally."
KCAS, an Integris BioServices company, is a contract research organization supporting today’s biotech, pharmaceutical, and animal health drug development programs. The company has been in business for over 40 years.
“KCAS is a multi-faceted company with a strong reputation in the bioscience sector,” Lieutenant Governor and Secretary of Commerce David Toland said. “Their innovative work provides highly attractive job opportunities for Kansans and will help keep our talent right here in the state.”
2022 Top States for Doing Business Provide an Environment for Business Growth
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Location Factors in the EV Industry — “Mission Critical” or “Nice to Have”?
2022 Auto/Aero Site Guide
How Are Economic Developers Partnering to Solve Workforce Challenges?
Fixing the Supply Chain with AI and Robotics
Three Big Challenges Facing the Food & Beverage Industry
Front Line: The Growth of Indoor and Vertical Farming